What Researchers Did
Researchers conducted a systematic review of five randomized controlled trials to evaluate the effectiveness of Extracorporeal Shock Wave Therapy (ESWT) for treating osteonecrosis and bone vascular diseases.
What They Found
The review included five studies with 199 patients (68 female and 131 male). While no major complications or serious adverse events were reported, the quality of the studies was generally poor, with only one ranked as "fair" and the rest as "poor." Based on the available data, ESWT showed potential for rapid pain relief and improved function.
What This Means for Canadian Patients
For Canadian patients experiencing osteonecrosis or bone vascular diseases, this review suggests that ESWT could be a potential non-surgical treatment option. However, the limited quality of current research means that more robust studies are needed to confirm its widespread effectiveness and safety.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
A significant limitation of this review is the overall substandard quality of method and relevant bias found in most of the included studies.